NFE2L2 and chronic kidney disease: In a mouse model of folic acid-induced AKI, specific deletion of GSK3β in renal tubules or treatment with a GSK3β inhibitor improved the Nrf2 antioxidant response, independently of Keap1, protecting from AKI to CKD transition [185].